Global Ophthalmic Drugs Market Size Study, by Disease Type (Dry Eye Drugs, Retinal Disorders Drugs, Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs, Anti-glaucoma Drugs), by Delivery Type (Capsules & Tablets, Gels, Eye drops, Eye ointment, Eye Solutions), by Product Type (Prescription Drugs and Over-the-Counter Drugs) and Regional Forecasts, 2017-2025

For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global Ophthalmic Drugs Market industry valued approximately USD 23.21 billion in 2016 is anticipated to grow with a healthy growth rate of more than 5.27% over the forecast period 2017-2025. Rising frequencies of eye disorders like mGlobal Ophthalmic Drugs Marketacular degeneration, presbyopia, and diabetic retinopathy among the most prevalent age groups are speculated to propel the growth.

The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

Disease Type:

  • Dry Eye Drugs
  • Retinal Disorders Drugs
  • Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs
  • Anti-Glaucoma Drugs

Delivery Type:

  • Capsules & Tablets
  • Gels
  • Eye Drops
  • Eye Ointment
  • Eye Solutions

Product Type:

  • Prescription Drugs
  • Over-the-Counter Drugs

Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2015

Base year – 2016

Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are Valeant Pharmaceuticals International, Inc., Sun Pharmaceutical Industries Ltd, Shire Plc, Regeneron Pharmaceuticals, Inc., Alcon, Pfizer Inc., Genentech, Inc., and Santen Pharmaceutical Co., Ltd. New product launches, acquisitions & effective mergers and focuses on continuous technology innovations are some of the strategies adopted by the key manufacturers. The companies are also trying to dominate the market by investing in research and development.

Target Audience of the Ophthalmic Drugs Market Study

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Chapter 1.           Global Ophthalmic Drugs Market Definition & Scope

1.1.         Objective of The Study

1.2.         Market Definition

1.3.         Scope of The Study

1.4.         Years Considered for The Study

1.5.         Currency Conversion Rates

1.6.         Report Limitation

Chapter 2.           Research Methodology

2.1.         Research Process

2.1.1.     Data Mining

2.1.2.     Analysis

2.1.3.     Market Estimation

2.1.4.     Validation

2.1.5.     Publishing

2.2.         Research Assumption

Chapter 3.           Executive Summary

3.1.         Key Trends

3.2.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Million)

Chapter 4.           Global Ophthalmic Drugs Industry Dynamics

4.1.         Growth Prospects

4.1.1.     Drivers

4.1.2.     Restraints

4.1.3.     Opportunities

4.2.         Industry Analysis

4.2.1.     Porter’s 5 Force Model

4.2.2.     PEST Analysis

4.2.3.     Value Chain Analysis

4.3.         Analyst Recommendation & Conclusion

Chapter 5.           Global Ophthalmic Drugs Market by Disease Type

5.1.         Market Snapshot

5.2.         Ophthalmic Drugs Market, Sub Segment Analysis

5.2.1.     Dry Eye Drugs

5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Million)

5.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

5.2.2.     Retinal Disorder Drugs

5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Million)

5.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

5.2.3.     Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs

5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Million)

5.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

5.2.4.     Anti-Glaucoma Drugs

5.2.4.1. Market estimates & forecasts, 2015-2025 (USD Million)

5.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

Chapter 6.           Global Ophthalmic Drugs Market by Delivery Type

6.1.         Market Snapshot

6.2.         Ophthalmic Drugs Market, Sub Segment Analysis

6.2.1.     Capsules & Tablets

6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Million)

6.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

6.2.2.     Gels

6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Million)

6.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

6.2.3.     Eye Drops

6.2.3.1. Market estimates & forecasts, 2015-2025 (USD Million)

6.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

6.2.4.     Eye Ointments

6.2.4.1. Market estimates & forecasts, 2015-2025 (USD Million)

6.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

6.2.5.     Eye Solutions

6.2.5.1. Market estimates & forecasts, 2015-2025 (USD Million)

6.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

Chapter 7.           Global Ophthalmic Drugs Market by Product Type

7.1.         Market Snapshot

7.2.         Ophthalmic Drugs Market, Sub Segment Analysis

7.2.1.     Prescription Drugs

7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Million)

7.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

7.2.2.     Over-the-Counter Drugs

7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Million)

7.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

Chapter 8.           Global Ophthalmic Drugs Market, Regional Analysis

8.1.         Ophthalmic Drugs Market, Regional Market Snapshot (2015-2025)

8.2.         North America Ophthalmic Drugs Market Snapshot

8.2.1.     U.S. Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.2.1.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.2.1.3. Mode of Application breakdown estimates & forecasts, 2015-2025 (USD Million)

8.2.1.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.2.2.     Canada Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.2.2.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.2.2.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.2.2.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.         Europe Ophthalmic Drugs Market Snapshot

8.3.1.     U.K. Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.3.1.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.1.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.1.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.2.     Germany Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.3.2.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.2.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.2.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.3.     France Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.3.3.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.3.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.3.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.4.     Rest of Europe Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.3.4.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.4.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.3.4.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.         Asia Ophthalmic Drugs Market Snapshot

8.4.1.     China Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.4.1.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.1.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.1.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.2.     India Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.4.2.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.2.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.2.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.3.     Japan Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.4.3.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.3.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.3.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.4.     Rest of Asia Pacific Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.4.4.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.4.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.4.4.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.5.         Latin America

8.5.1.     Brazil Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.5.1.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.5.1.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.5.1.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.5.2.     Mexico Ophthalmic Drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Million)

8.5.2.2. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.5.2.3. Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.5.2.4. Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.6.         Rest of The World Ophthalmic Drugs Market Snapshot

8.6.1.     Market estimates & forecasts, 2015-2025 (USD Million)

8.6.2.     Disease Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.6.3.     Delivery Type breakdown estimates & forecasts, 2015-2025 (USD Million)

8.6.4.     Product Type breakdown estimates & forecasts, 2015-2025 (USD Million)

Chapter 9.           Competitive Intelligence

9.1.         Company Market Share (Subject to Data Availability)

9.2.         Top Market Strategies

9.3.         Company Profiles

9.3.1.     Valeant Pharmaceuticals International Inc.

9.3.1.1. Overview

9.3.1.2. Financial (Subject to Data Availability)

9.3.1.3. Product Summary

9.3.1.4. Recent Developments

9.3.2.     Sun Pharmaceutical Industries Ltd.

9.3.3.     Shire Plc

9.3.4.     Regeneron Pharmaceuticals, Inc.

9.3.5.     Alcon

9.3.6.     Pfizer Inc.

9.3.7.     Genentech, Inc.

9.3.8.     Santen Pharmaceutical Co., Ltd

9.3.9.     Merck & Co., Inc.

9.3.10.   Allergan, Plc

 

The research for global Ophthalmic Drugs market focuses deeply on the entire value chain of the market. However, the market size estimates are purely based on the consumer side of the value chain wherein the market sizes have been calculated by analyzing the average demand for Ophthalmic Drugs across various end-uses such as the healthcare industry, and pharmaceuticals industry.

The revenue for global Ophthalmic Drugs market is calculated as sum market sizes of different segments such as product and regions Further, some other key data points considered to calculate the revenue for global Ophthalmic Drugs market include:

  • Revenues from key companies
  • Key company market share analysis
  • Consumer spending analysis
  • Regional export and import analysis
  • Sales revenue generated by various applications in different geographies

An extensive primary and secondary research has been conducted on key industry people, through questionnaires, telephonic conversations, email conversations, and interviews to verify the market estimations. Various government websites/portals and paid data sources are considered as a key source of secondary research.

We utilize a combination of bottom-up & top-down methodology for market estimations & forecasts. Additionally, we employ data triangulation techniques to verify each of the market estimates and forecasts through primary interviews and feedbacks.

All the estimates are derived from simulation models which is our proprietary technique. Each of these models is different from each other are a combination of correlation, regression and time series analysis. Each of these models is basically divided into two types namely economic and technological. Economical models are used to determine short-term market estimates and technological models are used for long-term estimates & forecasts.  


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,950

Enterprise License – $5,550

Loading…